TW Hsu, YH Su, HA Chen, PH Liao, SC Shen… - Aging (Albany …, 2023 - ncbi.nlm.nih.gov
Sorafenib, a small-molecule inhibitor targeting several tyrosine kinase pathways, is the
standard treatment for advanced hepatocellular carcinoma (HCC). However, not all patients …